BRIDGEWATER, N.J., and CHICAGO—Bausch + Lomb, a leading global eye health business, and Prevent Blindness, the nation’s oldest volunteer eye health non-profit organization, are collaborating throughout the month of February for the fifth consecutive year to raise awareness of Age-Related Macular Degeneration (AMD), one of the leading causes of vision loss in adults 50 years of age and older. It is estimated that as many as 16 million people in the U.S. are living with AMD, an eye disease that affects the macula, the part of the eye that supports sharp, central vision needed for seeing objects clearly.

Early-stage AMD often does not present any symptoms or changes in vision, as symptoms usually appear gradually over time. This progressive condition can impact one or both eyes, causing people to have difficulty with daily activities like driving, reading or recognizing the faces of loved ones.

Throughout February, Bausch + Lomb and Prevent Blindness will post a variety of content on their social media pages to share facts and helpful information about AMD with the public. Bausch + Lomb will also donate $1.00 to Prevent Blindness and its sight-saving fund for every “share” or “like” of certain posts that promote this donation from the Bausch + Lomb SightMatters Facebook page at https://www.facebook.com/SightMattersCommunity.

The companies also encourage people to visit SightMatters.com, an educational online resource that Bausch + Lomb created to help people with AMD better understand the condition and its progression. The website features personalized tips and tools and provides people with AMD the ability to create an action plan to manage their condition. They can also join the Sight Matters Facebook community to share their experiences and hear stories of others living with AMD.

“Each year, we look forward to joining forces with Bausch + Lomb to help bring awareness to this pervasive and potentially sight-stealing condition,” said Jeff Todd, president and CEO, Prevent Blindness. “Together we aim to encourage people to prioritize their eye health by scheduling a comprehensive, dilated eye exam—the best way to identify AMD—by providing essential resources they need to feel informed about this condition and understand the essential steps they need to take for prevention or if they are diagnosed.”

“Given the importance of vision on our lives, we understand those with AMD want to do everything they can, but often times are scared and unsure of what to do, or if what they are doing is right,” said Chris Marschall, vice president and general manager, U.S. Consumer Health Care, Bausch + Lomb.

“With SightMatters.com, people have a singular online resource where they can go to find easy-to-understand, action-oriented information that they need to help manage their condition—no matter where they are on their journey. We are committed to providing AMD patients with helpful resources and information to help support their lifelong vision health.”

Although there is no cure for AMD, there are steps that patients can take as part of a plan created with their doctor to help reduce their risk of progression. These steps include stopping smoking, exercising regularly, maintaining a healthy diet, and receiving a dilated eye exam.

Patients can also talk to their doctor about taking a vitamin based on the AREDS2 study. Only PreserVision AREDS 2 formula vitamins contain the exact nutrient formula recommended by the National Eye Institute to help reduce the risk of moderate to advanced AMD progression.

For more information about AMD, visit www.SightMatters.com. For a free listing of organizations and services that provide financial assistance for vision care in English or Spanish, visit Prevent Blindness at https://www.preventblindness.org/vision-care-financial-assistance-information.